How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?

Occupational exposure to antineoplastic agents at several departments in a hospital

P.J.M. Sessink, K. A. Boer, A. P. H. Scheefhals et al. · International Archives of Occupational and Environmental Health · 1992 · 273 citations

Public Health, Oncology, Occupational Health +13

The High Cost of Cancer Drugs and What We Can Do About It

Mustaqeem Siddiqui, S. Vincent Rajkumar · Mayo Clinic Proceedings · 2012 · 255 citations · Full text

Medicine, Oncology, Pharmacoeconomics +11

Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States

Thomas H. Connor, Roger W. Anderson, P.J.M. Sessink et al. · American Journal of Health-System Pharmacy · 1999 · 217 citations

Pharmacy, Oncology, Pharmaceutical Analysis +13

Using a closed-system protective device to reduce personnel exposure to antineoplastic agents

Catherine Wick, Matthew H. Slawson, James A. Jorgenson · American Journal of Health-System Pharmacy · 2003 · 160 citations

Pharmacy, Pharmacology, Pharmacy Practice +17

Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device

P.J.M. Sessink, Thomas H. Connor, James A. Jorgenson et al. · Journal of Oncology Pharmacy Practice · 2010 · 157 citations

Pharmacy, Pharmacology, Pharmacy Practice +13